Home » Regions » Global News » Evotec collaborates with Leukemia & Lymphoma Society

Evotec collaborates with Leukemia & Lymphoma Society

Wednesday, November 6, 2013

Evotec has entered into an integrated research collaboration with the Leukemia & Lymphoma Society (LLS). Evotec will support one of LLS’s Screen-to-Lead Programs (SLP).

Evotec partners with LLS to support selected programs and principal investigators with resources for high-throughput screening and optimization of small molecules into drug-like compounds. Evotec delivers an industrialized, comprehensive and unbiased drug discovery infrastructure to support innovation efficiency as part of a fully integrated solution.

Financial details were not disclosed.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!